A Systematic Review of the Psychiatric Side-Effects of Efavirenz
- 12 April 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in AIDS and Behavior
- Vol. 15 (8), 1803-1818
- https://doi.org/10.1007/s10461-011-9939-5
Abstract
Concerns regarding the use of efavirenz in patients with a history of mental illness may predispose clinicians to not offer this agent to psychiatrically ill populations in spite of the convenience of once daily dosing, which can result in improved adherence in these at-risk populations. This systematic review examines the current data regarding the neuropsychiatric effects of efavirenz, and also attempts to provide guidance to clinicians using efavirenz to treat patients with mental illness. The review identified high rates of neuropsychiatric side effects including vivid dreams, insomnia and mood changes in approximately 50% of patients who initiate efavirenz. The effects begin quickly, commonly peak in the first 2 weeks, and are generally mild and transient in nature. Isolated case reports and uncontrolled data suggest higher rates of severe side effects; however, there is no clear evidence of a broadly increased risk of suicide or dangerous behavior for patients taking efavirenz as part of their antiretroviral regimen.Keywords
This publication has 50 references indexed in Scilit:
- Adverse Drug Reactions to Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Regimen: A 24-Week Prospective StudyJournal of the International Association of Physicians in AIDS Care, 2009
- Psychosis in a 12-Year-Old HIV-Positive Girl with an Increased Serum Concentration of EfavirenzClinical Infectious Diseases, 2007
- Efavirenz: a reviewExpert Opinion on Pharmacotherapy, 2007
- Efavirenz and chronic neuropsychiatric symptoms: a cross‐sectional case control studyHIV Medicine, 2006
- Switch from Efavirenz to Nevirapine Associated with Resolution of Efavirenz-Related Neuropsychiatric Adverse Events and Improvement in Lipid ProfilesAIDS Patient Care and STDs, 2006
- Use of Efavirenz Is Not Associated with a Higher Risk of Depressive Disorders: A Substudy of the Randomized Clinical Trial ALIZE-ANRS 099Clinical Infectious Diseases, 2006
- Efavirenz Intoxication Due to Slow Hepatic MetabolismClinical Infectious Diseases, 2005
- A manic episode associated with efavirenz therapy for HIV infectionAIDS, 2003
- Efavirenz-induced catatoniaAIDS, 2002
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsThe New England Journal of Medicine, 1999